Uwe Pelzer

22PUBLICATIONS
66CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Feb 27, 2026
Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study.

Stephen L Chan, Thomas Yau, Robin K Kelley

|Jul 27, 2024
Smell and Taste Alterations in Patients Receiving Curative or Palliative Chemotherapy-The CONKO 021-ChemTox Trial.

Tobias Bleumer, Janine Abel, Wolfgang Böhmerle

|Apr 13, 2024
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer.

Faithlore P Gardner, Zev A Wainberg, Christos Fountzilas

|Apr 13, 2024
Intrahepatic Mass-Forming Cholangiocarcinoma: Is There Additional Prognostic Value in Using Gd-EOB Enhanced MRI?

Sebastian Halskov, Felix Krenzien, Laura Segger

|Mar 28, 2024
Cachexia-Affected Survival Based on Inflammatory Parameters Compared to Complex Conventional Nutritional Assessments in Patients with Pancreatic Cancer and Other Gastrointestinal Tumors-The CONKO 020 Investigation.

Johanna W Meyer-Knees, Janina Falkenthal, Dominik Geisel

|Nov 14, 2023
Correction: Felsenstein M. et al. Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies? <i>J. Clin. Med.</i> 2022, <i>11</i>, 2367.

Matthäus Felsenstein, Flora Lindhammer, Mathilde Feist

Pageof 4

Frequent Collaborators

8 joint publications

Thomas Malinka

7 joint publications

Uli Fehrenbach

6 joint publications

Sebastian Stintzing

5 joint publications

Dominik Geisel